The BSH Guidelines Official Podcast

• Lymphoma SIG Podcast 10 - BSH 2025 Highlights in Hodgkin Lymphoma with Professor Graham Collinsfirst line therapy for Hodgkins lymphoma

  In this episode, Professor Graham Collins shares with us the highlights in Hodgkin lymphoma from BSH 2025.  He takes us through the ECHELON-1 trial, which led to the recent NICE approval of Brentuximab-AVD as a frontline treatment option for advanced stage Hodgkin lymphoma.

  --------  

  11:57
• Lymphoma SIG Podcast 9 - Primary Mediastinal B-Cell lymphoma

  Professor Graham Collins discusses the management of primary mediastinal B-cell lymphoma, from initial treatment considerations to the management of relapsed disease.   Professor Collins is a Consultant Haematologist and the lymphoma lead clinician at the Oxford Cancer and Haematology Centre.  He has particular interests in Hodgkin and high-grade non-Hodgkin lymphoma and he chairs the national CAR-T panel for lymphoma.   Please note that since the recording of this podcast in December 2024, NICE has granted approval for the use of Liso-cel as a second-line treatment option in primary mediastinal B-cell lymphoma.

  --------  

  19:32
• Lymphoma SIG Podcast 8 - Bispecific T-cells engagers in Lymphoma

  Dr Sridhar Chaganti discusses the use of bispecific T-cell engagers (BITE’s) in large B-cell lymphoma.   Dr Chaganti is a consultant haematologist at University Hospitals Birmingham NHS Foundation Trust. He has a PhD in cancer studies from the University of Birmingham. His research interest is Epstein–Barr virus (EBV) and lymphomas. His special interests are in haematological malignancies, lymphomas, stem cell transplantation and cellular therapies.

  --------  

  31:26
• Lymphoma SIG Podcast 7 - Supportive Care in Lymphoma

  Dr Nikesh (Nik) Chavda discusses supportive care in lymphoma. Dr Chavda is a haematology consultant at University Hospitals Bristol and Weston, with an interest in B-cell malignancies, cellular therapies and histiocytic disorders.

  --------  

  22:17
• Lymphoma SIG Podcast 6 - Mycosis fungoides

  Dr Duncan Murray discusses mycosis fungoides and sezary syndrome. Dr Murray completed his PhD at the University of Birmingham, looking at the interaction between the immune system and malignant T cells in skin lymphoma. He finds the interaction between a "good" and "bad" T cell fascinating. He has used multiple single-cell laboratory techniques to tease apart the two populations (including V-beta antibodies, single-cell T-cell receptor (TCR) and ribonucleic acid (RNA) sequencing and mass cytometry). Skin lymphoma is an unusual disease in that key determinants of the patient's outcome sit very close together. Both anatomically and in phenotype. His current work focuses on what we can learn from high-dimensional single-cell data and the bioinformatic process to assist this.

  --------  

  36:11

Más podcasts de Salud y forma física

Podcasts a la moda de Salud y forma física

Acerca de The BSH Guidelines Official Podcast